Pharmacokinetics and tolerability of LIQ861, a novel dry-powder formulation of treprostinil

Roscigno, R; Vaughn, T; Anderson, S; Wargin, W; Hunt, T; Hill, NS

Hill, NS (corresponding author), Tufts Med Ctr, Pulm Div, 800 Washington St,Suite 257, Boston, MA 02111 USA.

PULMONARY CIRCULATION, 2020; 10 (4):

Abstract

A dry-powder inhaled formulation of treprostinil (LIQ861) produced using PRINT (R) technology offers a substantial advantage over current nebulized th......

Full Text Link